Director Dealing

RNS Number : 0441W
Byotrol PLC
06 February 2017
 

 

06 February 2017

 

Byotrol plc

 

("Byotrol" or the "Company")

 

Director Dealing

 

Byotrol plc, the specialist anti-microbial technology company, is pleased to announce that on 03 February 2016 John Langlands, Chairman of the Company has purchased 800,000 ordinary shares of 0.25p each ("Ordinary Shares") at a price of 4.195p per Ordinary Share (the "Purchase"). Following the Purchase, Mr. Langlands has an interest in 1,100,000 Ordinary Shares representing 0.41% of the total voting rights of the Company.

Enquiries:

Byotrol plc

01925 742 000

David Traynor - Chief Executive

 

 

 

finnCap Ltd

 

020 7220 0500

(Nominated Adviser & Broker)

 

Geoff Nash/Carl Holmes/James Thompson - Corporate Finance

 

Mia Gardner - Corporate Broking

 

 

 

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

Notes to Editors:

 

Byotrol plc (BYOT.L), quoted on AIM, is a specialist in developing, formulating and commercialising cutting-edge antimicrobial technologies.

Our patented suite of technologies delivers powerful broad-spectrum efficacy with residual performance optimised against commonly occurring and industry-specific pathogens

 

Founded in 2005, the Company has developed the technology that creates easier, safer and cleaner lives.

For more information, please go to www.byotrol.co.uk

 

1.               

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

John Langlands

2.               

Reason for the Notification

a)

Position/status

Chairman

b)

Initial notification/Amendment

Initial

3.   

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Byotrol Plc

b)

LEI

N/A

4.   

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

ordinary shares of 0.25p each

Identification code

GB00B0999995

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

  Volume(s)

4.195p

  800,000

 

 

 

d)

Aggregated information:

·     Aggregated volume

·     Price

800,000 ordinary shares of 0.25p each purchased at 4.195p per ordinary share

e)

Date of the transaction

03 February 2017

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

 

 

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHDMGGZNFLGNZM
UK 100

Latest directors dealings